Literature DB >> 8391815

A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines.

M Ichimura1, H Kase.   

Abstract

Cytosolic phosphodiesterase activities of Jurkat, a human T-lymphocyte cell line, were resolved by high performance liquid chromatography into two major peaks of cAMP-specific enzyme. One was the Rolipram-sensitive isozyme. The other showed a low Km value (0.45 +/- 0.04 microM) for cAMP and different properties from reported isozymes in that it was hardly affected by well-known phosphodiesterase inhibitors or activators. This enzyme, "JK-21", was found in other human T-cell lines, MOLT-4, HPB-ALL and HUT-78, whereas no fraction containing JK-21 was detected in human B-lymphocyte cell lines, Jijoye, JY and Namalwa and in human promyelocytic cell line, HL-60. The results indicate that JK-21 is a new phosphodiesterase isozyme localized to T-cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391815     DOI: 10.1006/bbrc.1993.1722

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase.

Authors:  J M Hetman; S H Soderling; N A Glavas; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.

Authors:  N A Glavas; C Ostenson; J B Schaefer; V Vasta; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 3.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants.

Authors:  T J Bloom; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2.

Authors:  M A Giembycz; C J Corrigan; J Seybold; R Newton; P J Barnes
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.

Authors:  X Jiang; J Li; M Paskind; P M Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Regulation by phosphodiesterase isoenzymes of non-adrenergic non-cholinergic contraction in guinea-pig isolated main bronchus.

Authors:  D Spina; S Harrison; C P Page
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors.

Authors:  A Nakata; K Ogawa; T Sasaki; N Koyama; K Wada; J Kotera; H Kikkawa; K Omori; O Kaminuma
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 9.  Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions.

Authors:  Marianna Szczypka
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.